<scp>IDH1</scp>/2 inhibitor monotherapy in blast‐phase myeloproliferative neoplasms: A multicentre experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IDH1/2 inhibitor monotherapy in blast‐phase myeloproliferative neoplasms: A multicentre experience

Published:2023-08-03 Issue:3 Volume:203 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Gangat Naseema¹^ORCID,Ajufo Helen²,Abdelmagid Maymona¹,Karrar Omer¹,McCullough Kristen¹,Badar Talha³^ORCID,Foran James³^ORCID,Palmer Jeanne⁴,Alkhateeb Hassan¹^ORCID,Mangaonkar Abhishek¹^ORCID,Kuykendall Andrew⁵^ORCID,Rampal Raajit K.²,Tefferi Ayalew¹^ORCID

Affiliation:

1. Division of Hematology Mayo Clinic Rochester Minnesota USA

2. Leukemia Service, Department of Medicine Memorial Sloan Kettering New York New York USA

3. Division of Hematology Mayo Clinic Jacksonville Florida USA

4. Division of Hematology Mayo Clinic Scottsdale Arizona USA

5. Division of Hematology Moffitt Cancer Center Tampa Florida USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19027

Reference15 articles.

1. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

2. Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts

3. Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival

4. Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

5. Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Outcomes of Accelerated and Blast-Phase Myeloproliferative Neoplasms;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Challenging Scenarios in the Management of Myeloproliferative Neoplasms;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era;Blood Advances;2024-06-28

4. Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification ofDYRK1A;2023-12-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3